These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9786475)

  • 1. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
    Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
    J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
    Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M; Uematsu T; Kosuge K; Okuyama Y; Morino A; Ozaki M; Takebe Y
    J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
    Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.
    Stass H; Dalhoff A; Kubitza D; Schühly U
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2060-5. PubMed ID: 9687407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental pharmacokinetics of the new fluoroquinolone DW-116 in pregnant rats.
    Kim JC; Bae CS; Kim SH; Yun HI; Park SC; Shin HC; Han J; Chung MK
    Toxicol Lett; 2003 Apr; 142(1-2):103-9. PubMed ID: 12765244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
    Gajjar DA; Bello A; Ge Z; Christopher L; Grasela DM
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2256-63. PubMed ID: 12821477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
    Mant TG
    Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
    Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
    Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
    Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
    J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats.
    Yu IL; Chung SJ; Lee MH; Shim CK
    J Pharm Sci; 1997 May; 86(5):550-3. PubMed ID: 9145377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of single oral doses of lomefloxacin.
    Morse IS
    Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
    Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
    J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers.
    Tanaka M; Tamura K; Atarashi S; Kubo Y; Oliver SD; Bentley M; Hakusui H
    Xenobiotica; 1995 Nov; 25(10):1119-25. PubMed ID: 8578768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
    Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
    J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age and gender on the pharmacokinetics of grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():9-17. PubMed ID: 9433651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
    Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
    Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.